The Proteomics Shared Resource provides AECC researchers with comprehensive mass spectrometry technologies for analysis of proteins, peptides, carbohydrates, lipids and. unknowns. Staff scientists plan and execute proteomics-based analyses, carry out intensive data analysis, and interact closely with AECC scientists on all aspects of their experiments. Services include: MALDI-TOF, ESI- and FT-ICR mass spectrometry;bioinformatics searches and customized data analysis;2D-gels, 2D-DIGE and high-resolution HPLC;rapid turnaround time for protein ID from gel bands, immunoaffinity isolations or specialty preparations;identification of components of protein complexes;post-translational modifications of proteins;protocols and training in methods and data acquisition;quantitative proteomics using SILAC, SILAM, ^?0, iTRAQ and label-free methods;protein dynamics and biomolecular interactions using hydrogen/deuterium exchange-mass spectrometry;confirmation of synthetic and recombinant molecules;and high-resolution analysis by FT-ICR-MS of metabolites, drugs, peptides and small molecules. Quantitative mass spectrometry experiments have assumed new importance in the past project period, and are anticipated to continue to increase. New services include: (i) imaging mass spectrometry, whereby frozen tissue sections can be analyzed for small proteins or small molecules, transmitters or metabolites and (ii) triple quadrupole mass spectrometry for the quantitative analysis of drugs and their metabolites in biological fluids. The science of the AECC members helps to drive the technology offered in the facility. For example, the demand for imaging mass spectrometry led to the successful shared instrumentation grant application that awarded funds for its implementation. Studies of protein dynamics involve close interactions with several AECC faculty and have been helpful in designing new drug candidates. Analysis of kinetic isotope effects (KIE) is utilized in the design of transition- state inhibitors. The Proteomics Shared Resource provides training on the analytical tools available to users such as the MASCOT search engine and associated modules. Protein Scaffold, ProteolQ, MSnbase to integrate quantitative proteomics with statistical analysis, and specialized software for Selected Reaction Monitoring. A Proteomics course is offered which provides instruction in advanced data analysis.
The Proteomics Shared Resource provides comprehensive mass spectrometry technologies for analysis of proteins, peptides, carbohydrates, lipids and unknowns that support the translational research mission and goals of the Albert Einstein Cancer Center (AECC). As an NCI-designated Cancer Center, AECC contributes to the national effort to reduce morbidity and mortality from cancer.
|Peregrina, Karina; Houston, Michele; Daroqui, Cecilia et al. (2015) Vitamin D is a determinant of mouse intestinal Lgr5 stem cell functions. Carcinogenesis 36:25-31|
|Kim, Ryung S (2015) A new comparison of nested case-control and case-cohort designs and methods. Eur J Epidemiol 30:197-207|
|Stanley, Pamela (2014) Galectin-1 Pulls the Strings on VEGFR2. Cell 156:625-6|
|Yamane, Fumihiro; Nishikawa, Yumiko; Matsui, Kazue et al. (2014) CSF-1 receptor-mediated differentiation of a new type of monocytic cell with B cell-stimulating activity: its selective dependence on IL-34. J Leukoc Biol 95:19-31|
|Arora, Pooja; Baena, Andres; Yu, Karl O A et al. (2014) A single subset of dendritic cells controls the cytokine bias of natural killer T cell responses to diverse glycolipid antigens. Immunity 40:105-16|
|Bahde, Ralf; Kapoor, Sorabh; Viswanathan, Preeti et al. (2014) Endothelin-1 receptor A blocker darusentan decreases hepatic changes and improves liver repopulation after cell transplantation in rats. Hepatology 59:1107-17|
|Ho, Gloria Y F; Wang, Tao; Zheng, Siqun L et al. (2014) Circulating soluble cytokine receptors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 23:179-88|
|Singh, M; Quispe-Tintaya, W; Chandra, D et al. (2014) Direct incorporation of the NKT-cell activator ?-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy. Br J Cancer 111:1945-54|
|Kerns, Sarah L; de Ruysscher, Dirk; Andreassen, Christian N et al. (2014) STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics. Radiother Oncol 110:182-8|
|Hiraki, Susan; Rinella, Erica S; Schnabel, Freya et al. (2014) Cancer risk assessment using genetic panel testing: considerations for clinical application. J Genet Couns 23:604-17|
Showing the most recent 10 out of 938 publications